E178: Elon Musk of Biotech: How David Berry Built 7 Unicorns

episode

How I Invest with David Weisburd not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from How I Invest with David Weisburd

E430: Goldman Sachs’ Michael Bruun on AI, Private Equity & The War for Talent 37 min · 16 Sep 2026

E429: Dr. V on AI, Market Bubbles & Finding the Next Anthropic 36 min · 14 Sep 2026

E428: Michael Green on Peter Thiel, SpaceX, and Inefficient Markets 46 min · 11 Sep 2026

E427: AQR's Peter Hecht on AI, Market Bubbles & How the Best Investors Build Portfolios 1h 5m · 09 Sep 2026

E426: American Securities CEO on Warren Buffett, Private Equity & Playing the Long Game 54 min · 07 Sep 2026

E425: What 30,000 Founders Taught Me About AI, Judgment & Top Founders 1h 3m · 04 Sep 2026

All episodes from How I Invest with David Weisburd →

Report any issue

Source

Recorded23 Jun 2025

Publisherfeeds.podcastai.com ↗

Handlerec:395302

Show notes

David Berry is one of the most prolific healthcare entrepreneurs of our time. In this episode, we discuss his transition from scientist to founder to investor, what it takes to scale transformational health companies, and how his firm Averin is helping usher in the next wave of AI-enabled healthcare. We also talk about his early experience launching a satellite at 14, how he's co-founded over 30 companies—including seven unicorns—and why patents, perseverance, and purpose are the trifecta behind lasting innovation.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in